Evidence map›Paper›PMID 25816103›Full record

ArticlePloS one2015

Analysis of the cytotoxicity of carbon-based nanoparticles, diamond and graphite, in human glioblastoma and hepatoma cell lines.

Karolina Ewa Zakrzewska, Anna Samluk, Mateusz Wierzbicki, Sławomir Jaworski, Marta Kutwin, Ewa Sawosz, André Chwalibog, Dorota Genowefa Pijanowska, Krzysztof Dariusz Pluta

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Diamond thin films: giving biomedical applications a new shine.Journal of the Royal Society, Interface · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Karolina Ewa ZakrzewskaDepartment of Hybrid Microbiosystem Engineering, Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw, Poland.
Anna SamlukDepartment of Hybrid Microbiosystem Engineering, Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw, Poland.
Mateusz WierzbickiDivision of Nanobiotechnology, Faculty of Animal Science, Warsaw University of Life Sciences, Warsaw, Poland.
Sławomir JaworskiDivision of Nanobiotechnology, Faculty of Animal Science, Warsaw University of Life Sciences, Warsaw, Poland.
Marta KutwinDivision of Nanobiotechnology, Faculty of Animal Science, Warsaw University of Life Sciences, Warsaw, Poland.
Ewa SawoszDivision of Nanobiotechnology, Faculty of Animal Science, Warsaw University of Life Sciences, Warsaw, Poland.
André ChwalibogDepartment of Veterinary Clinical and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Dorota Genowefa PijanowskaDepartment of Hybrid Microbiosystem Engineering, Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw, Poland.
Krzysztof Dariusz PlutaDepartment of Hybrid Microbiosystem Engineering, Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw, Poland.
Institute of Biocybernetics and Biomedical Engineering · PLWarsaw University of Life Sciences · PLUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles have attracted a great deal of attention as carriers for drug delivery to cancer cells. However, reports on their potential cytotoxicity raise questions of their safety and this matter needs attentive consideration. In this paper, for the first time, the cytotoxic effects of two carbon based nanoparticles, diamond and graphite, on glioblastoma and hepatoma cells were compared. First, we confirmed previous results that diamond nanoparticles are practically nontoxic. Second, graphite nanoparticles exhibited a negative impact on glioblastoma, but not on hepatoma cells. The studied carbon nanoparticles could be a potentially useful tool for therapeutics delivery to the brain tissue with minimal side effects on the hepatocytes. Furthermore, we showed the influence of the nanoparticles on the stable, fluorescently labeled tumor cell lines and concluded that the labeled cells are suitable for drug cytotoxicity tests.

Indexed as

CarbonCarcinoma, HepatocellularCell Line, TumorCell ProliferationCell SurvivalDiamondDrug Delivery SystemsGlioblastomaGraphiteHepatocytesHumansLiver NeoplasmsNanoparticlesCarbonDiamondGraphite

Identifiers

PMID25816103
PMCPMC4376528
OpenAlexW1989159677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.